中医药治疗人类高致病性冠状病毒SARS-CoV-2与SARS-CoV感染肺炎的思考  

Consideration of traditional Chinese medicine in treatment of highly pathogenic human coronaviruses SARS-CoV-2 and SARS-CoV

作　　者：杨羽君 鄂秀辉[1,2] 任红微 何毅 周水平[1,2] YANG Yu-jun;E Xiu-hui;REN Hong-wei;HE Yi;ZHOU Shui-ping(Tasly Academy,Tasly Pharmaceutical Group Co.,Ltd.,Tianjin 300410,China;Key Laboratory of Critical Technology in Innovative Chinese Medicine,Tasly Pharmaceutical Group Co.,Ltd.,Tianjin 300410,China)

机构地区：[1]天士力控股集团有限公司研究院,天津300410 [2]天士力医药集团股份有限公司创新中药关键技术国家重点实验室,天津300410

出　　处：《中草药》2020年第6期1427-1434,共8页Chinese Traditional and Herbal Drugs

基　　金：国家科技重大专项“中医药优势领域的创新中药关键技术开发研究”(2017ZX09301005)。

摘　　要：近日所爆发的新型冠状病毒肺炎(COVID-19)与2003年爆发的严重急性呼吸综合征(SARS)均具有广泛的流行性、较强的传染性、较高的致病性,给我国的生产、生活和人民健康造成了重大的影响,也给经济带来了巨大的损失。这2种疾病分别是由人类高致病性冠状病毒SARS-Co V-2与SARS-CoV感染所致。中医药作为我国特有的诊疗手段,在保障人民健康中发挥着至关重要的作用。通过对比2种肺炎的流行病学、临床表现、中医药治疗原则及手段等,提出中医药在预防、治疗及恢复期对于2种疫病治疗的共性及区别,并给出相应建议。Recently, the coronavirus disease 2019(COVID-19) has broken out in China, similar with the sever acute respiratory syndrome(SARS) outbroke in 2003, this pestilence has wide epidemic, strong infectivity and high pathogenicity, which led a great impact on the production, life and people’s health in China, and brought huge losses to the economy as well. These two kinds of pestilence were caused by human highly pathogenic coronavirus SARS-CoV-2 and SARS-CoV, respectively. Traditional Chinese medicine, as a unique medical way from China, plays an indelible role in ensuring people’s health. By comparing the epidemiology, clinical manifestations, therapeutic principles and methods of traditional Chinese medicine, this paper puts forward the similarities and differences of traditional Chinese medicine in the prevention, treatment and recovery periods in COVID-19 and SARS, and gives corresponding suggestions.

关 键 词：SARS-CoV-2 新型冠状病毒肺炎 SARS-COV 严重急性呼吸综合征 高致病性冠状病毒 中医药 

分 类 号：R285[医药卫生—中药学]